Joseph Seitlinger
Overview
Explore the profile of Joseph Seitlinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guerrera F, Lococo F, Fournel L, Viggiano D, Mangiameli G, Mastromarino M, et al.
Eur J Surg Oncol
. 2025 Feb;
51(6):109592.
PMID: 40009921
Objectives: In recent years, targeted therapy and immunotherapy have been demonstrated to improve survival in non-operable, non-small cell lung cancer (NSCLC) patients. The results of salvage lung resection in patients...
2.
Seitlinger J, Patel D, Meng A, Bulgarelli-Maqueda L, Cools-Lartigue J, Sirois C, et al.
Clin Lung Cancer
. 2024 Nov;
26(1):e55-e62.e1.
PMID: 39550247
Background: Lung cancer remains the leading cause of cancer-related deaths worldwide. Recent studies have highlighted the benefit of neo-adjuvant therapies in the treatment of resectable stage IB to IIIA cases...
3.
Streit A, Walsh L, Stasiak F, Vautrin N, Guerci P, Seitlinger J, et al.
J Robot Surg
. 2024 Sep;
18(1):351.
PMID: 39325298
Management of acute and chronic pain after thoracic surgery for pulmonary resection or thymectomy remains a challenge for both thoracic surgeons and anesthesiologists. Advances in minimally invasive robotic procedures have...
4.
Seitlinger J, Stasiak F, Streit A, Wollbrett C, Siat J, Schnedecker L, et al.
J Thorac Dis
. 2024 Sep;
16(8):4986-4993.
PMID: 39268137
Background: The widespread deployment of screening programs has increased the number of suspected pulmonary nodules diagnosed. The main objective of this retrospective study was to evaluate the concordance between needle-based...
5.
Wollbrett C, Seitlinger J, Stasiak F, Piccoli J, Streit A, Siat J, et al.
J Cardiothorac Surg
. 2024 Mar;
19(1):145.
PMID: 38504315
Background: Mapping of the pulmonary lymphatic system by near-infrared (NIR) fluorescence imaging might not always identify the first lymph node relay. The aim of this study was to determine the...
6.
Pilon Y, Rokah M, Seitlinger J, Sepesi B, Rayes R, Cools-Lartigue J, et al.
Clin Lung Cancer
. 2024 Feb;
25(3):e133-e144.e4.
PMID: 38378398
Background: Several regulatory agencies have approved the use of the neoadjuvant chemo-immunotherapy for resectable stage II and III of non-small cell lung cancer (NSCLC) and numerous trials investigating novel agents...
7.
Streit A, Lampridis S, Seitlinger J, Renaud S, Routledge T, Bille A
Curr Oncol Rep
. 2023 Dec;
26(1):55-64.
PMID: 38133722
Purpose Of Review: With increased detection of early-stage non-small cell lung cancer (NSCLC) owing to screening, determining optimal management increasingly hinges on assessing resectability and operability. Resectability refers to the...
8.
Piccoli J, Seitlinger J, Streit A, Wollbrett C, Siat J, Renaud S
Interdiscip Cardiovasc Thorac Surg
. 2023 Aug;
37(5).
PMID: 37572306
Objectives: Although segmentectomy is steadily increasing in early-stage non-small-cell lung cancer, recurrence in the ipsilateral lobe is also increasing. Completion lobectomy (CL) is a challenging procedure that has already been...
9.
Nounsi A, Seitlinger J, Ponte C, Demiselle J, Idoux-Gillet Y, Pencreach E, et al.
Biomedicines
. 2023 Jul;
11(7).
PMID: 37509464
Radiation therapy and platinum-based chemotherapy are common treatments for lung cancer patients. Several factors are considered for the low overall survival rate of lung cancer, such as the patient's physical...
10.
Seitlinger J, Spicer J
J Thorac Cardiovasc Surg
. 2023 Apr;
166(5):1340-1346.
PMID: 37115120
No abstract available.